Compile Data Set for Download or QSAR
Report error Found 52 Enz. Inhib. hit(s) with all data for entry = 50012740
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122205((R)-4-{4-[3-(1H-Benzoimidazol-2-ylamino)-propylami...)
Affinity DataIC50: 0.400nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122205((R)-4-{4-[3-(1H-Benzoimidazol-2-ylamino)-propylami...)
Affinity DataIC50: 0.400nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122219((R)-4-{4-[4-(1H-Benzoimidazol-2-ylamino)-piperidin...)
Affinity DataIC50: 1nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122204((S)-3-{4-[4-(1H-Benzoimidazol-2-ylamino)-piperidin...)
Affinity DataIC50: 1nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122198((S)-3-(4-{4-[(1H-Benzoimidazol-2-ylamino)-methyl]-...)
Affinity DataIC50: 1.30nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122192((S)-3-(4-{4-[(1H-Benzoimidazol-2-ylamino)-methyl]-...)
Affinity DataIC50: 1.30nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122227((S)-3-(4-{4-[(1H-Benzoimidazol-2-ylamino)-methyl]-...)
Affinity DataIC50: 1.5nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122195((S)-3-(4-{4-[(1H-Benzoimidazol-2-ylamino)-methyl]-...)
Affinity DataIC50: 1.5nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122225((S)-2-Benzyloxycarbonylamino-3-{5-methyl-2-oxo-4-[...)
Affinity DataIC50: 2.40nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122222((R)-3-Benzyloxycarbonylamino-4-{4-[3-(1H-imidazol-...)
Affinity DataIC50: 3nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122216((R)-3-Benzyloxycarbonylamino-4-{4-[2-(1H-imidazol-...)
Affinity DataIC50: 3.60nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122228((S)-2-Benzyloxycarbonylamino-3-(4-{[2-(3-benzyl-ur...)
Affinity DataIC50: 4.20nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122218((S)-3-{4-[4-(1H-Benzoimidazol-2-yl)-piperidin-1-yl...)
Affinity DataIC50: 9.40nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122202((S)-2-Benzyloxycarbonylamino-3-{5-methyl-2-oxo-4-[...)
Affinity DataIC50: 10nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122198((S)-3-(4-{4-[(1H-Benzoimidazol-2-ylamino)-methyl]-...)
Affinity DataIC50: 10nMAssay Description:Inhibition of alphaV-beta5 integrin binding to vitronectin in adhesion assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122220((R)-4-(4-{4-[2-(1H-Benzoimidazol-2-ylamino)-ethyl]...)
Affinity DataIC50: 10nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122229((S)-3-(4-{4-[(1H-Benzoimidazol-2-ylamino)-methyl]-...)
Affinity DataIC50: 12nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122211((S)-3-(4-{4-[2-(1H-Benzoimidazol-2-ylamino)-ethyl]...)
Affinity DataIC50: 15nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122237((S)-3-(4-{4-[(1H-Benzoimidazol-2-ylamino)-methyl]-...)
Affinity DataIC50: 16nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122214((R)-4-{4-[4-(1H-Benzoimidazol-2-ylamino)-butylamin...)
Affinity DataIC50: 17nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122203((S)-3-{4-[4-(1H-Benzoimidazol-2-ylmethyl)-piperidi...)
Affinity DataIC50: 18nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122217((R)-4-{4-[2-(1H-Benzoimidazol-2-ylcarbamoyl)-ethyl...)
Affinity DataIC50: 19nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122230((R)-3-Benzyloxycarbonylamino-4-{5-methyl-2-oxo-4-[...)
Affinity DataIC50: 36nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122231((R)-3-Benzyloxycarbonylamino-4-{4-[4-(3-benzyl-ure...)
Affinity DataIC50: 39nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122199((S)-3-{4-[4-(1H-Benzoimidazol-2-ylamino)-butylamin...)
Affinity DataIC50: 47nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122212((R)-3-Benzyloxycarbonylamino-4-(4-{[2-(3-benzyl-ur...)
Affinity DataIC50: 48nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122221((S)-3-{4-[3-(1H-Benzoimidazol-2-ylamino)-propylami...)
Affinity DataIC50: 61nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122206((S)-2-Benzyloxycarbonylamino-3-{4-[3-(1H-imidazol-...)
Affinity DataIC50: 76nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122207((S)-2-Benzyloxycarbonylamino-3-{4-[4-(3-benzyl-ure...)
Affinity DataIC50: 82nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122224((S)-3-{4-[5-(1H-Benzoimidazol-2-ylamino)-pentylami...)
Affinity DataIC50: 103nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122193((R)-4-(4-{4-[(1H-Benzoimidazol-2-ylamino)-methyl]-...)
Affinity DataIC50: 130nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122205((R)-4-{4-[3-(1H-Benzoimidazol-2-ylamino)-propylami...)
Affinity DataIC50: 300nMAssay Description:Inhibition of alphaV-beta5 integrin binding to vitronectin in adhesion assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122197((R)-4-{4-[5-(1H-Benzoimidazol-2-ylamino)-pentylami...)
Affinity DataIC50: 500nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122236((R)-3-Benzyloxycarbonylamino-4-(4-{[4-(3-benzyl-ur...)
Affinity DataIC50: 500nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122198((S)-3-(4-{4-[(1H-Benzoimidazol-2-ylamino)-methyl]-...)
Affinity DataIC50: 500nMAssay Description:Inhibition of alphaV-beta3 integrin binding to osteopontin in adhesion assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122196((R)-4-{4-[4-(1H-Benzoimidazol-2-yl)-piperidin-1-yl...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122223((S)-3-(4-{4-[(1H-Benzoimidazol-2-ylamino)-methyl]-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122232((S)-2-Benzyloxycarbonylamino-3-{5-methyl-2-oxo-4-[...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122215((S)-2-Benzyloxycarbonylamino-3-[5-methyl-2-oxo-4-(...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122198((S)-3-(4-{4-[(1H-Benzoimidazol-2-ylamino)-methyl]-...)
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of alphaIIb-beta3 integrin binding to fibrinogen in ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122201((S)-2-Benzyloxycarbonylamino-3-{4-[2-(1H-imidazol-...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122205((R)-4-{4-[3-(1H-Benzoimidazol-2-ylamino)-propylami...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of alphaIIb-beta3 integrin binding to fibrinogen in ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122200((R)-4-{4-[4-(Benzooxazol-2-ylaminomethyl)-piperidi...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122209((R)-3-Benzyloxycarbonylamino-4-{5-methyl-2-oxo-4-[...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122226((S)-2-Benzyloxycarbonylamino-3-(4-{[4-(3-benzyl-ur...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122210((S)-3-{4-[2-(1H-Benzoimidazol-2-ylcarbamoyl)-ethyl...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122213((S)-3-{4-[4-(Benzothiazol-2-ylaminomethyl)-piperid...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122194((S)-3-{4-[4-(Benzooxazol-2-ylaminomethyl)-piperidi...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122234((R)-4-[4-(4-Benzylcarbamoyloxy-benzylamino)-5-meth...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Basf

Curated by ChEMBL
LigandPNGBDBM50122208((S)-2-Benzyloxycarbonylamino-3-[4-(4-benzyloxycarb...)
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibitory concentration against alphaV-beta3 integrin using vitronectin ELISA assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
Displayed 1 to 50 (of 52 total ) | Next | Last >>
Jump to: